Publication | Open Access
FOSL1 promotes tumor growth and invasion in ameloblastoma
17
Citations
19
References
2022
Year
FOSL1 promotes tumor recurrence and invasive growth in AM by modulating kinetochore metaphase signaling and the epithelial-mesenchymal transition pathway; thus, it represents a promising therapeutic target for AM treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1